As per the latest market research conducted by FMI, the global phosphatidylserine market is expected to record a CAGR of 5.3% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of USD 178.19 million. By 2033, the valuation is anticipated to be worth USD 298.1 million.
The amino acid derivative phosphatidylserine is a substance that simulates dietary fat and is widely distributed in human cerebral tissue. Phosphatidylserine often comes in the form of a white or light yellow loose powder, although there is also a small amount of liquid as it is essential for mental function. Supplementing with phosphatidylserine appears to enhance memory and cognitive function in elderly people, thus increasing the revenue share of the phosphatidylserine supplement market
Significant Market Trends:
| Attributes | Value |
|---|---|
| Phosphatidylserine Value (2022) | USD 169.48 million |
| Phosphatidylserine Market Expected Value (2023) | USD 178.19 million |
| Phosphatidylserine Market Forecast Value (2033) | USD 298.1 million |
| Phosphatidylserine Market Expected CAGR (2023 to 2033) | 5.3% |
Explore FMI!
Book a free demo
Phosphatidylserine is manufactured in low purity and has an unpleasant odor. It is high in neutral oil and fatty acids. To achieve such high purity levels for usage in nutritional supplements, nutraceuticals, etc., purification procedures including ultrafiltration, supercritical CO2 extraction, and solvent extraction are used.
A few of the primary obstacles preventing the phosphatidylserine market from expanding include a highly complex production method and a niche market. Yet, Western nations like the United States, Canada, the United Kingdom, Germany, etc. are starting to see a rise in the popularity of healthy eating as a result of rising health consciousness. Dietary supplements are used to maintain a healthy diet and lifestyle. Supplements containing phosphatidylserine have several positive health effects.
In order to appeal to consumers who are concerned about their health, key players in the phosphatidylserine supplement market are also providing products that are gluten-free, salt-free, sugar-free, starch-free, fish-free, etc. During the forecast period, the phosphatidylserine market is anticipated to have a favorable outlook.
One of the main reasons impeding the expansion of the global phosphatidylserine market is the low adoption rate of dietary supplements and functional foods in many emerging economies, along with the rise in the use of counterfeit goods. Also, the absence of global regulations governing the production and use of phosphatidylserine is anticipated to slow market expansion during the forecast period. Phosphatidylserine production and used and governed by a wide range of national regulations, which deters industry investment and restrains market expansion.
| Market Statistics | Details |
|---|---|
| H1,2021 (A) | 5.0% |
| H1,2022 Projected (P) | 5.1% |
| H1,2022 Outlook (O) | 5.6% |
| BPS Change : H1,2022 (O) - H1,2022 (P) | (+) 51 ↑ |
| BPS Change : H1,2022 (O) - H1,2021 (A) | (+) 56.1 ↑ |
The growth rates of the global market and its potential for future expansion are compared and evaluated by FMI every six months. Certain demographic and innovative elements of the market are dominant as a result of the subjective effects of macro- and industry-level variables.
A considerable portion of nutritional supplements, functional foods, nutraceuticals, and cosmetics available today are exclusively derived from plant-based materials. Growing awareness of animal rights and welfare as well as increased health concerns have sparked demand for plant-based cuisine. Phosphatidylserine is in high demand because of its benefits for cognitive function. It applies to both the food and pharmaceutical industries.
Several Sectors have Undergone Recent Developments, Including:
The global phosphatidylserine market expanded by 5.0% during the first half of 2021. However, not all areas have seen this rise equally; the developing markets have seen a rate of growth of 5.6 % (H1 2022 Expected). As a result, there was a 56.1 BPS point difference between H1 2022's expected growth and predicted growth.
In 2021, Asia Pacific dominated the phosphatidylserine market, followed by Europe and North America. Phosphatidylserine consumption is increasing as a result of the introduction of e-commerce platforms as well as the presence of a strong retail infrastructure in China, India, and other ASEAN countries. These factors are also increasing the demand for dietary supplements, functional foods, and medical foods.
The low acceptance rate of dietary supplements and functional food components in many emerging economies, as well as the rise in the usage of fraudulent goods, are two primary obstacles preventing the growth of the global phosphatidylserine market. Also, it is projected that the lack of international rules governing the manufacturing and use of phosphatidylserine is expected to restrain market growth.
| Country | United States |
|---|---|
| CAGR (2018 to 2022) | 3.6% |
| CAGR (2023 to 2033) | 5.6% |
| Valuation (2033) | USD 104.91 million |
| Country | United Kingdom |
|---|---|
| CAGR (2018 to 2022) | 4.6% |
| CAGR (2023 to 2033) | 5.8% |
| Valuation (2033) | USD 12.74 million |
| Country | China |
|---|---|
| CAGR (2018 to 2022) | 4.8% |
| CAGR (2023 to 2033) | 6.7% |
| Valuation (2033) | USD 15.12 million |
| Country | Germany |
|---|---|
| CAGR (2018 to 2022) | 4.1% |
| CAGR (2023 to 2033) | 4.7% |
| Valuation (2033) | USD 6.23 million |
Consumers who are More Health Conscious are Consuming more Dietary Supplements and Functional Foods, which is Driving the Phosphatidylserine Market
Due to the dietary supplements act, which the United States government passed in 1994, nutritional supplements saw a surge in popularity in North America in the 1990s, particularly in the United States. The market for nutritional supplements in the United States has undergone significant growth throughout the years. Urban residents now consume much more nutritional supplements to help them cope with the psychological stress brought on mostly by their hectic lifestyles.
The high consumption of dietary supplements in Western nations like the United States and Europe, as well as the rising consumption in emerging economies like China and India, are what is driving the market for phosphatidylserine for dietary supplement products.
A sizable population in the United States uses dietary supplements for their health and well-being driving the market in the nation. Therefore, the end-user segment of the global phosphatidylserine market is likely to be dominated by the dietary supplements sub-segment.
The United States Food and Drug Administration's GRAS designation of phosphatidylserine is one of the factors encouraging its expansion in other industries as well as its use in dietary supplements. Phosphatidylserine is now a common ingredient in new products due to funding.
Functional foods including breakfast cereals, dairy product imitations (imitation milk, soy milk), nutritional bars, processed superfruit and fruit juices, yogurt, etc. all contain phosphatidylserine.
Also, the United States FDA approved the phosphatidylserine health claim for the treatment of memory loss and cognitive impairment in 2003. Its approval has prompted researchers to add phosphatidylserine to medical products, particularly for disorders that affect memory, such as Alzheimer's disease and dementia.
The cosmetic industry now uses very little phosphatidylserine, but this is projected to change as spending on research and development rises. The Food and Drug Administration's approval and grant are serving as a catalyst, propelling the global phosphatidylserine market.
Many consumers today are interested in the components and, to some extent, the provenance of the products they buy. The vast amount of dietary supplements, functional foods, nutraceuticals, and cosmetics purchased today are made with only substances sourced from plants. This demand for plant-based foods is brought on by rising health concerns as well as growing knowledge of animal welfare and rights.
Consumers rejected phosphatidylserine derived from cow brains after the late 1990s outbreak of the dangerous condition known as mad cow disease, which was caused by bovine spongiform encephalopathy. Manufacturers began using raw materials that weren't derived from animals as a result of this changeover, which caused the market equation to change. Notably, plant-derived phosphatidylserine was in greater demand in the global phosphatidylserine market.
| Attribute | Details |
|---|---|
| Market Size Value in 2023 | USD 178.19 million |
| Market Forecast Value in 2033 | USD 298.1 million |
| Global Growth Rate | 5.3% CAGR |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | MT for Volume and USD million for Value |
| Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, The Middle East and Africa, and Oceania |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Chile, Peru, Poland, Germany, Italy, Spain, France, United Kingdom, BENELUX, Nordic, Russia, China, Japan, Korea, Indonesia Malaysia, Singapore, India, Taiwan, and Thailand |
| Key Market Segments Covered | Form, End User, Grade, Nature, Source, and Region |
| Key Companies Profiled | Lonza AG; Enzymotec Ltd; Lipogen Products Ltd.; Doosan Corporation; Novastell; Nagase ChemteX Corporation; Bontac Bio-engineering (Shenzhen) Co. Ltd.; ECA Healthcare, Inc.; Lipoid GmbH; Chemi Nutra LLC; Others |
| Pricing | Available upon Request |
Leading firms in the global market for phosphatidylserine are using inorganic strategies and joining forces with other market players to develop alliances, partnerships, mergers, and acquisitions to increase their global reach.
The market is valued at USD 178.1 million in 2023.
Lonza AG, Enzymotec Ltd., and Lipogen Products Ltd. are the leading competitors in the market.
The market is anticipated to record a CAGR of 5.3% through 2033.
High demand from the pharmaceutical industry to fuel the market.
The United States is predicted to expand at a CAGR of 5.6% through 2033.
A detailed analysis of the Australia Mezcal industry and growth outlook covering product, source, concentration, and distribution channel segment
Comprehensive Analysis of Europe Mezcal Market by Product, Source, Concentration, Distribution Channel and Country through 2035
Comprehensive Analysis of ASEAN Mezcal Market by Product, By Source, By concentration, By sales Channel and Region through 2035
USA Snack Pellets Industry Analysis from 2025 to 2035
USA Non-Alcoholic Malt Beverages Industry Analysis from 2025 to 2035
USA Monoprotein Industry Analysis from 2025 to 2035
Phosphatidylserine Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
